Catheter ablation of sustained idiopathic right ventricular outflow tract tachycardia in a pregnant patient without fluoroscopy
- Authors: Govorova Y.O.1, Pershina E.S.2, Tyukov P.A.3, Alekhnovich A.V.1, Lischuk A.N.1, Gromyko G.A.1,4
-
Affiliations:
- Vishnevsky A.A. 3 Central Military Clinical Hospital
- City Сlinical Hospital №1 Pirogov N.I.
- Regional Clinical Hospital
- Medical Institute of Lifelong Learning, Moscow State University of Food Production
- Issue: Vol 2, No 1 (2022)
- Pages: 41-46
- Section: Case reports
- URL: https://journal-vniispk.ru/cardar/article/view/101549
- DOI: https://doi.org/10.17816/cardar101549
- ID: 101549
Cite item
Full Text
Abstract
In 2020, our department has performed 739 operations on nonpregnant patients. Additionally, 545 highly successful nonfluoroscopic catheter ablation of cardiac arrhythmias were routinely performed using a three-dimensional navigation system, including 47 patients with idiopathic ventricular tachycardia (VT) from the right ventricular outflow tract (RVOT).
A 38-year-old female patient with a structurally normal heart was admitted to our hospital in 10–11 weeks of her third pregnancy because she sustained recurrent 166 regular heartbeats per minute, wide QRS-complex tachycardia with left bundle branch morphology, and frequent premature ventricular contractions on Holter monitoring with complaints of presyncope and dyspnea. Standard antiarrhythmic drugs failed to control tachycardia. This case report presents our initial successful experience of the rescue zero-fluoroscopy catheter ablation of sustained poorly tolerated idiopathic RVOT tachycardia in a pregnant patient. Our result suggests that this technique may be considered in the few rare cases in which drug-resistant, sustained frequent VT is accompanied by hemodynamic compromise with fluoroscopy contraindication.
AIM: Diagnostic algorithm of idiopathic sustained drug-resistant, poorly tolerated VT and the possibility of radiofrequency catheter ablation in the most vulnerable first trimester of pregnancy without fluoroscopy were presented in our case report.
Full Text
##article.viewOnOriginalSite##About the authors
Yulia O. Govorova
Vishnevsky A.A. 3 Central Military Clinical Hospital
Email: jgovorova9@gmail.com
ORCID iD: 0000-0001-7096-310X
cardiologist at the Cardiosurgery Center
Russian Federation, KrasnogorskEkaterina S. Pershina
City Сlinical Hospital №1 Pirogov N.I.
Email: pershina86@mail.ru
ORCID iD: 0000-0002-3952-6865
SPIN-code: 7311-9276
Cand. of Sci. (Med.)
Russian Federation, MoscowPavel A. Tyukov
Regional Clinical Hospital
Email: ptukov@mail.ru
ORCID iD: 0000-0001-8974-0416
Cardiovascular surgeon at the Cardiosurgery Center
Russian Federation, VologdaAlexander V. Alekhnovich
Vishnevsky A.A. 3 Central Military Clinical Hospital
Author for correspondence.
Email: vmnauka@mail.ru
ORCID iD: 0000-0001-8851-9138
SPIN-code: 3507-2688
MD, PhD, Professor
Russian Federation, KrasnogorskAlexander N. Lischuk
Vishnevsky A.A. 3 Central Military Clinical Hospital
Email: AlexLischuk@yandex.ru
ORCID iD: 0000-0003-0285-5486
SPIN-code: 1255-2035
MD, PhD, Professor
Russian Federation, KrasnogorskGrigory A. Gromyko
Vishnevsky A.A. 3 Central Military Clinical Hospital; Medical Institute of Lifelong Learning, Moscow State University of Food Production
Email: gromyko2010@list.ru
ORCID iD: 0000-0002-7942-9795
SPIN-code: 3041-8555
Cand. of Sci. (Med.)
Russian Federation, Krasnogorsk; MoscowReferences
- Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Eur Heart J. 2015;36(41):2793–2867. doi: 10.1093/eurheartj/ehv316
- van Hagen IM, Boersma E, Johnson MR, et al. Global cardiac risk assessment in the registry of pregnancy and cardiac disease: Results of a registry from the European Society of Cardiology. Eur J Heart Fail. 2016;18(5):523–533. doi: 10.1002/ejhf.501
- Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–3241. doi: 10.1093/eurheartj/ehy340
- Haugaa KH, Haland TF, Leren IS, et al. Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis. Europace. 2016;18(7);965–972. doi: 10.1093/europace/euv340
- Corrado D, Perazzolo Marra M, Zorzi A, et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol. 2020;319:106–114. doi: 10.1016/j.ijcard.2020.06.005
- Bauersachs1 J, König T, van der Meer P, et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019;21(7):827–843. doi: 10.1002/ejhf.1493
- Yamada T. Idiopathic ventricular arrhythmias Relevance to the anatomy, diagnosis and treatment. J Cardiol. 2016;68(6):463–471. doi: 10.1016/j.jjcc.2016.06.001
- Li M-M, Sang C-H, Jiang C-X, et al. Maternal arrhythmia in structurally normal heart: Prevalence and feasibility of catheter ablation without fluoroscopy. Pacing Clin Electrophysiol. 2019;42(12):1566–1572. doi: 10.1111/pace.13819
- Guangzhi C, Ge S, Renfan X, et al. Zero-fluoroscopy catheter ablation of severe drug-resistant arrhythmia guided by Ensite NavX system during pregnancy: Two case reports and literature review. Medicine. 2016;95(32):e4487. doi: 10.1097/MD.0000000000004487
Supplementary files
